MCE - Delayed Quote EUR

Laboratorio Reig Jofre, S.A. (RJF.MC)

3.1000
0.0000
(0.00%)
At close: May 19 at 5:35:24 PM GMT+2
Loading Chart for RJF.MC
  • Previous Close 3.1000
  • Open 3.1200
  • Bid 3.0600 x --
  • Ask 3.1100 x --
  • Day's Range 3.0600 - 3.1200
  • 52 Week Range 2.4600 - 3.3800
  • Volume 506
  • Avg. Volume 37,481
  • Market Cap (intraday) 248.223M
  • Beta (5Y Monthly) 0.87
  • PE Ratio (TTM) 23.85
  • EPS (TTM) 0.1300
  • Earnings Date Jul 25, 2025
  • Forward Dividend & Yield 0.05 (1.58%)
  • Ex-Dividend Date May 15, 2025
  • 1y Target Est --

Laboratorio Reig Jofre, S.A., a pharmaceutical company, engages in the research, development, manufacture, and marketing of pharmaceutical products and specialties, as well as accessories authorized foodstuffs, dietary and personal care products, and cosmetics. The company offers nutritional and parapharmacy products. Its products also include pharmaceutical technologies products, such as antibiotics, and injectables and other products; specialty pharmacare products, which include skin, hair, nails, joint health and pain, and women's health; and food supplements under the Forté Pharma brand. In addition, the company provides CDMO and CMO services; and management and administration services. It sells its products through business partners. The company was founded in 1929 and is headquartered in Barcelona, Spain. Laboratorio Reig Jofre, S.A. operates as a subsidiary of Reig Jofre Investments SL.

www.reigjofre.com

--

Full Time Employees

December 31

Fiscal Year Ends

Recent News: RJF.MC

View More

Performance Overview: RJF.MC

Trailing total returns as of 5/19/2025, which may include dividends or other distributions. Benchmark is IBEX 35... (^IBEX) .

YTD Return

RJF.MC
25.05%
IBEX 35... (^IBEX)
22.21%

1-Year Return

RJF.MC
15.43%
IBEX 35... (^IBEX)
24.46%

3-Year Return

RJF.MC
63.93%
IBEX 35... (^IBEX)
67.73%

5-Year Return

RJF.MC
90.93%
IBEX 35... (^IBEX)
113.33%

Compare To: RJF.MC

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: RJF.MC

View More

Valuation Measures

Annual
As of 5/16/2025
  • Market Cap

    248.22M

  • Enterprise Value

    290.67M

  • Trailing P/E

    23.85

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    0.73

  • Price/Book (mrq)

    1.16

  • Enterprise Value/Revenue

    0.86

  • Enterprise Value/EBITDA

    8.03

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    3.09%

  • Return on Assets (ttm)

    2.73%

  • Return on Equity (ttm)

    5.01%

  • Revenue (ttm)

    338.9M

  • Net Income Avi to Common (ttm)

    10.47M

  • Diluted EPS (ttm)

    0.1300

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    23M

  • Total Debt/Equity (mrq)

    27.48%

  • Levered Free Cash Flow (ttm)

    --

Research Analysis: RJF.MC

View More

Company Insights: RJF.MC

Research Reports: RJF.MC

View More

People Also Watch